Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schenk

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
The Pharmacogenomics Journal|November 4, 2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patientsP W Schenk, M van Vliet, R A A Mathot, et al.
Molecular Psychiatry|August 2, 2007
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patientsP W Schenk, M A C van Fessem, S Verploegh-Van Rij, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 4, 2011
Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter surveyA Simon, E Müllenborn, M Prelog, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?Céline L van Lint, Paul J M van der Boog, Fred P H T M Romijn, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Clinical Chemistry and Laboratory Medicine|August 31, 2022
Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementationEsther van Andel, Linda M Henricks, Alex P M Giliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Factors affecting cytochrome P-450 3A activity in cancer patientsSharyn D Baker, Ron H N van Schaik, Laurent P Rivory, et al.
Nature Communications|November 18, 2021
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancerMaximilian W Schenk, Sam Humphrey, A S Md Mukarram Hossain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patientsErin R Lepper, Sharyn D Baker, Matt Permenter, et al.
JMIR Public Health and Surveillance|January 26, 2025
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort StudyMaaike C Swets, Steven R Kerr, Brian MacKenna, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
The Pharmacogenomics Journal|November 4, 2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patientsP W Schenk, M van Vliet, R A A Mathot, et al.
Molecular Psychiatry|August 2, 2007
Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patientsP W Schenk, M A C van Fessem, S Verploegh-Van Rij, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 4, 2011
Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter surveyA Simon, E Müllenborn, M Prelog, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Application of a point of care creatinine device for trend monitoring in kidney transplant patients: fit for purpose?Céline L van Lint, Paul J M van der Boog, Fred P H T M Romijn, et al.
British Journal of Pharmacology|November 15, 2018
Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeuticsAlice Lallo, Sakshi Gulati, Maximilian W Schenk, et al.
Clinical Chemistry and Laboratory Medicine|August 31, 2022
Moving average quality control of routine chemistry and hematology parameters - a toolbox for implementationEsther van Andel, Linda M Henricks, Alex P M Giliams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Factors affecting cytochrome P-450 3A activity in cancer patientsSharyn D Baker, Ron H N van Schaik, Laurent P Rivory, et al.
Nature Communications|November 18, 2021
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancerMaximilian W Schenk, Sam Humphrey, A S Md Mukarram Hossain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patientsErin R Lepper, Sharyn D Baker, Matt Permenter, et al.
JMIR Public Health and Surveillance|January 26, 2025
Using Laboratory Test Results for Surveillance During a New Outbreak of Acute Hepatitis in 3-Week- to 5-Year-Old Children in the United Kingdom, the Netherlands, Ireland, and Curaçao: Observational Cohort StudyMaaike C Swets, Steven R Kerr, Brian MacKenna, et al.
Pageof 9